FI20060501A7 - Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa - Google Patents

Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa Download PDF

Info

Publication number
FI20060501A7
FI20060501A7 FI20060501A FI20060501A FI20060501A7 FI 20060501 A7 FI20060501 A7 FI 20060501A7 FI 20060501 A FI20060501 A FI 20060501A FI 20060501 A FI20060501 A FI 20060501A FI 20060501 A7 FI20060501 A7 FI 20060501A7
Authority
FI
Finland
Prior art keywords
stomach
composition
acetaldehyde
compound
binding acetaldehyde
Prior art date
Application number
FI20060501A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20060501A0 (fi
FI20060501L (fi
Inventor
Mikko Salaspuro
Osmo Suovaniemi
Ville Salaspuro
Martti Marvola
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20060501A priority Critical patent/FI20060501A7/fi
Publication of FI20060501A0 publication Critical patent/FI20060501A0/fi
Priority to CN200780026340.XA priority patent/CN101668522B/zh
Priority to JP2009511536A priority patent/JP2009538832A/ja
Priority to PT77307742T priority patent/PT2049097T/pt
Priority to PCT/FI2007/050288 priority patent/WO2007135242A1/en
Priority to EA200802361A priority patent/EA021063B1/ru
Priority to DK07730774.2T priority patent/DK2049097T3/da
Priority to PCT/FI2007/050287 priority patent/WO2007135241A2/en
Priority to ES07730774T priority patent/ES2845635T3/es
Priority to EA200802360A priority patent/EA019832B1/ru
Priority to KR1020137019534A priority patent/KR20130099217A/ko
Priority to PL07730774T priority patent/PL2049097T3/pl
Priority to EP07730775A priority patent/EP2034982A1/en
Priority to EP07730774.2A priority patent/EP2049097B1/en
Priority to HUE07730774A priority patent/HUE052428T2/hu
Priority to KR1020137002597A priority patent/KR20130020733A/ko
Priority to US12/301,906 priority patent/US20090253793A1/en
Priority to KR1020087031142A priority patent/KR20090030272A/ko
Priority to US12/301,925 priority patent/US8758812B2/en
Priority to SI200732169T priority patent/SI2049097T1/sl
Priority to JP2009511537A priority patent/JP5394235B2/ja
Priority to CNA2007800273492A priority patent/CN101489545A/zh
Priority to LTEP07730774.2T priority patent/LT2049097T/lt
Priority to KR1020087031178A priority patent/KR20090015986A/ko
Publication of FI20060501L publication Critical patent/FI20060501L/fi
Publication of FI20060501A7 publication Critical patent/FI20060501A7/fi
Priority to JP2013098512A priority patent/JP2013177413A/ja
Priority to JP2013161521A priority patent/JP6178657B2/ja
Priority to JP2016147411A priority patent/JP2016196500A/ja
Priority to CY20211100066T priority patent/CY1123875T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Dairy Products (AREA)
FI20060501A 2006-05-22 2006-05-22 Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa FI20060501A7 (fi)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FI20060501A FI20060501A7 (fi) 2006-05-22 2006-05-22 Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
KR1020087031178A KR20090015986A (ko) 2006-05-22 2007-05-22 위에서 아세트알데하이드를 결합시키기 위한 조성물 및 방법
HUE07730774A HUE052428T2 (hu) 2006-05-22 2007-05-22 Készítmény és eljárás acetaldehid gyomorban való megkötésére
KR1020137002597A KR20130020733A (ko) 2006-05-22 2007-05-22 위에서 아세트알데하이드를 결합시키기 위한 조성물 및 방법
PT77307742T PT2049097T (pt) 2006-05-22 2007-05-22 Composição e método para ligar acetaldeído no estômago
PCT/FI2007/050288 WO2007135242A1 (en) 2006-05-22 2007-05-22 Composition for foodstuff for binding acetaldehyde
EA200802361A EA021063B1 (ru) 2006-05-22 2007-05-22 Пищевая композиция, связывающая ацетальдегид, и ее применение
DK07730774.2T DK2049097T3 (da) 2006-05-22 2007-05-22 Sammensætning og fremgangsmåde til at binde acetaldehyd i maven
PCT/FI2007/050287 WO2007135241A2 (en) 2006-05-22 2007-05-22 Composition and method for binding acetaldehyde in stomach
ES07730774T ES2845635T3 (es) 2006-05-22 2007-05-22 Composición y método para la unión de acetaldehído en el estómago
EA200802360A EA019832B1 (ru) 2006-05-22 2007-05-22 Применение композиции и способ связывания ацетальдегида в желудке
KR1020137019534A KR20130099217A (ko) 2006-05-22 2007-05-22 위에서 아세트알데하이드를 결합시키기 위한 조성물 및 방법
PL07730774T PL2049097T3 (pl) 2006-05-22 2007-05-22 Kompozycja i sposób wiązania aldehydu octowego w żołądku
EP07730775A EP2034982A1 (en) 2006-05-22 2007-05-22 Composition for foodstuff for binding acetaldehyde
EP07730774.2A EP2049097B1 (en) 2006-05-22 2007-05-22 Composition and method for binding acetaldehyde in stomach
CN200780026340.XA CN101668522B (zh) 2006-05-22 2007-05-22 用于结合胃中乙醛的组合物和方法
KR1020087031142A KR20090030272A (ko) 2006-05-22 2007-05-22 아세트알데히드를 결합시키는 식료품을 위한 조성물
JP2009511537A JP5394235B2 (ja) 2006-05-22 2007-05-22 アセトアルデヒドを結合するための食品用組成物
US12/301,906 US20090253793A1 (en) 2006-05-22 2007-05-22 Composition and method for binding acetaldehyde in stomach
US12/301,925 US8758812B2 (en) 2006-05-22 2007-05-22 Composition for foodstuff for binding acetaldehyde
SI200732169T SI2049097T1 (sl) 2006-05-22 2007-05-22 Sestavki in metoda za vezavo acetaldehida v želodcu
JP2009511536A JP2009538832A (ja) 2006-05-22 2007-05-22 胃内でアセトアルデヒドを結合するための組成物および方法
CNA2007800273492A CN101489545A (zh) 2006-05-22 2007-05-22 用于结合乙醛的食物组合物
LTEP07730774.2T LT2049097T (lt) 2006-05-22 2007-05-22 Kompozicija ir būdas, skirti acetaldehidui surišti skrandyje
JP2013098512A JP2013177413A (ja) 2006-05-22 2013-05-08 アセトアルデヒドを結合するための食品用組成物
JP2013161521A JP6178657B2 (ja) 2006-05-22 2013-08-02 胃内でアセトアルデヒドを結合するための組成物および方法
JP2016147411A JP2016196500A (ja) 2006-05-22 2016-07-27 胃内でアセトアルデヒドを結合するための組成物および方法
CY20211100066T CY1123875T1 (el) 2006-05-22 2021-01-27 Συνθεση και μεθοδος για τη δεσμευση ακεταλδεϋδης στο στομαχι

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80212006P 2006-05-22 2006-05-22
FI20060501A FI20060501A7 (fi) 2006-05-22 2006-05-22 Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa

Publications (3)

Publication Number Publication Date
FI20060501A0 FI20060501A0 (fi) 2006-05-22
FI20060501L FI20060501L (fi) 2007-11-23
FI20060501A7 true FI20060501A7 (fi) 2007-11-23

Family

ID=38436750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060501A FI20060501A7 (fi) 2006-05-22 2006-05-22 Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa

Country Status (16)

Country Link
US (2) US20090253793A1 (cg-RX-API-DMAC10.html)
EP (2) EP2034982A1 (cg-RX-API-DMAC10.html)
JP (5) JP2009538832A (cg-RX-API-DMAC10.html)
KR (4) KR20090030272A (cg-RX-API-DMAC10.html)
CN (2) CN101668522B (cg-RX-API-DMAC10.html)
CY (1) CY1123875T1 (cg-RX-API-DMAC10.html)
DK (1) DK2049097T3 (cg-RX-API-DMAC10.html)
EA (2) EA021063B1 (cg-RX-API-DMAC10.html)
ES (1) ES2845635T3 (cg-RX-API-DMAC10.html)
FI (1) FI20060501A7 (cg-RX-API-DMAC10.html)
HU (1) HUE052428T2 (cg-RX-API-DMAC10.html)
LT (1) LT2049097T (cg-RX-API-DMAC10.html)
PL (1) PL2049097T3 (cg-RX-API-DMAC10.html)
PT (1) PT2049097T (cg-RX-API-DMAC10.html)
SI (1) SI2049097T1 (cg-RX-API-DMAC10.html)
WO (2) WO2007135241A2 (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171296A1 (en) * 2000-10-30 2011-07-14 Biohit Oyj Method and preparation for binding acetaldehyde in saliva, the stomach and the large intestine
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
FI20060501A7 (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
DE102011001768A1 (de) 2011-04-04 2012-10-04 Gunnar Frank Präparat oder Nahrungsergänzungsmittel
FI20115377A (fi) * 2011-04-18 2012-10-19 Biohit Oyj Ylempien hengitys- ja ruoansulatuselinten mikrobi-infektioihin liittyvissä tiloissa käytettäväksi tarkoitettuja lääketieteellisiä tuotteita
ITMI20120847A1 (it) * 2012-05-16 2013-11-17 Labomar S R L Formulazione per sostanze a bassa biodisponibilità.
FI129157B (en) 2012-05-28 2021-08-13 Biohit Oyj Composition for use in reducing the incidence of or preventing severe headaches
JP2016514120A (ja) * 2013-03-12 2016-05-19 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 胃腸管においてアルデヒドを結合するための経口投与用組成物
BR112015006048A2 (pt) * 2013-03-12 2017-07-04 Biohit Oyj composição encapsulada para ligação com aldeídos no estômago
FI20135503L (fi) * 2013-05-13 2014-11-14 Biohit Oyj Kysteiini tai sen johdannainen atrofisen gastriitin hoitamiseen
FI20145217A7 (fi) * 2014-03-06 2015-09-07 Biohit Oyj Koostumus aldehydien ja vapaiden radikaalien sitomiseksi ruoansulatuskanavassa
CN105267267A (zh) * 2014-06-05 2016-01-27 樊伟 L-半胱氨酸组合物在预防、清除（或消除）吸烟、饮酒时所产生的致癌因素乙醛的应用
FI127823B (en) * 2015-03-06 2019-03-15 Biohit Oyj Composition for preventing hangover symptoms
JP6009050B1 (ja) * 2015-08-21 2016-10-19 国立大学法人東北大学 飲酒による悪酔いまたは二日酔いの軽減または予防剤
US11717554B2 (en) * 2019-09-19 2023-08-08 Max R&D Llc Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
PH22818A (en) * 1986-02-18 1989-01-19 Takeda Chemical Industries Ltd Composition and method for reducing acetaldehyde toxicity
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
JPH0421635A (ja) 1990-05-16 1992-01-24 Suntory Ltd アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物
JPH0789876A (ja) * 1993-09-20 1995-04-04 Shiseido Co Ltd 徐放性製剤
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
EP0886519A1 (en) * 1996-11-01 1998-12-30 Ilex Oncology, Inc. Sustained release formulation containing dfmo
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
US6303607B1 (en) * 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation
DZ2937A1 (fr) * 1998-11-12 2004-03-15 Smithkline Beecham Plc Compositions nouvelles de sensibilidants à l'insuline.
JP2000178194A (ja) * 1998-12-18 2000-06-27 Pola Chem Ind Inc 徐放性製剤
FI121528B (fi) * 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
JP3715529B2 (ja) * 2000-12-19 2005-11-09 雅嗣 田中 アルコール代謝促進剤
DE10224170A1 (de) * 2002-05-31 2003-12-11 Desitin Arzneimittel Gmbh Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung
DE10224655B4 (de) * 2002-06-03 2005-03-10 Deuter Sport & Leder Rucksack mit integriertem Kleinkindersitz
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
WO2004066924A2 (en) * 2003-01-24 2004-08-12 Andrx Labs Llc Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
US20050271754A1 (en) 2004-06-07 2005-12-08 Cochrane Patrick W Composition for prevention or treatment of an alcohol hangover
JP5654726B2 (ja) * 2004-10-08 2015-01-14 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 唾液中のアルデヒド類を結合するための方法および製剤
FI122914B (fi) * 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi
FI20060501A7 (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa

Also Published As

Publication number Publication date
KR20130099217A (ko) 2013-09-05
FI20060501A0 (fi) 2006-05-22
KR20090015986A (ko) 2009-02-12
JP2009537613A (ja) 2009-10-29
PL2049097T3 (pl) 2021-05-31
FI20060501L (fi) 2007-11-23
US20100239663A1 (en) 2010-09-23
WO2007135241A2 (en) 2007-11-29
JP2016196500A (ja) 2016-11-24
SI2049097T1 (sl) 2021-05-31
EA200802360A1 (ru) 2010-02-26
WO2007135242A1 (en) 2007-11-29
JP2009538832A (ja) 2009-11-12
ES2845635T3 (es) 2021-07-27
CY1123875T1 (el) 2022-05-27
CN101489545A (zh) 2009-07-22
KR20090030272A (ko) 2009-03-24
EA200802361A1 (ru) 2009-06-30
JP2013177413A (ja) 2013-09-09
WO2007135241A3 (en) 2009-09-17
EP2049097A2 (en) 2009-04-22
EA019832B1 (ru) 2014-06-30
US8758812B2 (en) 2014-06-24
KR20130020733A (ko) 2013-02-27
CN101668522A (zh) 2010-03-10
EA021063B1 (ru) 2015-03-31
DK2049097T3 (da) 2021-01-25
JP6178657B2 (ja) 2017-08-09
LT2049097T (lt) 2021-02-10
US20090253793A1 (en) 2009-10-08
HUE052428T2 (hu) 2021-04-28
PT2049097T (pt) 2021-02-04
EP2049097B1 (en) 2020-11-04
CN101668522B (zh) 2015-06-24
EP2034982A1 (en) 2009-03-18
JP2013231080A (ja) 2013-11-14
JP5394235B2 (ja) 2014-01-22

Similar Documents

Publication Publication Date Title
CY1123875T1 (el) Συνθεση και μεθοδος για τη δεσμευση ακεταλδεϋδης στο στομαχι
EP2021797A4 (en) N-2,2,4-bis (1,1-dimethylethyl) -5-hydroxy-phenyl-1,4-dihydro-4-oxoquinol-3-carboxamide
WO2007081740A3 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
NO20092611L (no) Krystallinsk faststoff Rasagilin base
MY146969A (en) Dpp iv inhibitor formulations
NO20092632L (no) Jern (III)-basert fosfatadsorbent, fremgangsmåte for fremstilling derav, anvendelser derav og farmasøytisk preparat inneholdende nevnte adsorbent.
WO2008136865A3 (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
ZA200805413B (en) Method for modifying gut flora in animals
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
MX2020005214A (es) Formulaciones de anticuerpos.
PT1948155E (pt) Composições farmacêuticas contendo droxidopa
EP2856885A3 (en) Protein hydrolysate compositions having enhanced cck releasing ability
TR201902512T4 (tr) Isıya ve ışığa karşı stabilize edilmiş poliamid bileşimi.
EP1881020A4 (en) POLYMERIC DERIVATIVE OF A METABOLIC ANTAGONIST OF CYTIDINE
TW200621313A (en) Pharmaceutical compositions
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
UA86119C2 (ru) Амидные пролекарства гемцитабина, их композиции и применение
UA91204C2 (ru) Композиция для преодоления опосредствованной бета-лактамазой резистентности к антибиотикам с использованием ингибитора бета-лактамазы, предназначенная для инъекции
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
WO2009070507A3 (en) Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma
EP1991248A4 (en) ANTIDEPRESSANT PRODRUGS
EA200702037A1 (ru) Пищевая композиция для связывания ацетальдегида во рту и пищевом тракте и способ её приготовления
MX2008009830A (es) Efecto del inhibidor bst2.
EA200800393A1 (ru) Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат
MX2010001075A (es) Derivados de n-piperidin-4-ilmetil-amida y su uso como inhibidores de recaptacion del neurotransmisor de monoamina.

Legal Events

Date Code Title Description
FD Application lapsed